QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Canaccord Adams Cardiovascular Conference at the Waldorf-Astoria hotel in New York on Tuesday, November 13, 2007. Eamonn Hobbs, President and CEO of AngioDynamics, will present a review of the Company’s business strategy and historical financial results at 3:15 p.m. Eastern Time.